Takeda’s dengue vaccine: Europe’s Committee for Medicinal Products for Human Use recommends approval
by Press Release from Outbreak News Today on (#64RC4)
NewsDesk @bactiman63 On Friday, Takeda announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the approval of Takeda's dengue vaccine candidate, TAK-003, for the prevention of dengue disease caused by any serotype in individuals four years of age and older in Europe and in dengue-endemic countries participating in [...]
The post Takeda's dengue vaccine: Europe's Committee for Medicinal Products for Human Use recommends approval appeared first on Outbreak News Today.